---
figid: PMC8583909__ijms-22-11833-g001
figtitle: Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in
  Non-Small Cell Lung Cancer
organisms:
- Homo sapiens
- Mus musculus
- Armoracia rusticana
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8583909
filename: ijms-22-11833-g001.jpg
figlink: /pmc/articles/PMC8583909/figure/ijms-22-11833-f001/
number: F1
caption: '(A) Epidermal growth factor receptor (EGFR) pathway. The figure emphasizes
  the main signaling cascades: mitogen-activated protein kinase (MAPK), signal transducer
  and activator of transcription 3 (STAT3), and mammalian target of rapamycin (mTOR).
  (B) Differences between the activation mechanism of wild-type and mutant EGFR; the
  figure shows the role of tyrosine kinase inhibitors (TKIs) in the inhibition of
  EGFR by competing with ATP for the binding to the tyrosine domain kinase (TK).'
papertitle: Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in
  Non-Small Cell Lung Cancer.
reftext: Cristina Minnelli, et al. Int J Mol Sci. 2021 Nov;22(21):11833.
year: '2021'
doi: 10.3390/ijms222111833
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: epigallocatechin-3-gallate (EGCG) | epidermal growth factor receptor (EGFR)
  | tyrosine kinase inhibitors (TKIs) | non-small cell lung cancer (NSCLC)
automl_pathway: 0.8194304
figid_alias: PMC8583909__F1
figtype: Figure
redirect_from: /figures/PMC8583909__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8583909__ijms-22-11833-g001.html
  '@type': Dataset
  description: '(A) Epidermal growth factor receptor (EGFR) pathway. The figure emphasizes
    the main signaling cascades: mitogen-activated protein kinase (MAPK), signal transducer
    and activator of transcription 3 (STAT3), and mammalian target of rapamycin (mTOR).
    (B) Differences between the activation mechanism of wild-type and mutant EGFR;
    the figure shows the role of tyrosine kinase inhibitors (TKIs) in the inhibition
    of EGFR by competing with ATP for the binding to the tyrosine domain kinase (TK).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tk
  - Egfr
  - Egf
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Akt1
  - Mtor
  - Stat3
  - TK1
  - TK2
  - ATP8A2
  - EGFR
  - EGF
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - STAT3
  - Tk
  - ATPsynbeta
  - Atpalpha
  - Ras64B
  - Ras85D
  - thi
  - thiv
  - peb
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tor
---
